Introduction
Standardizing the outcomes that are used in clinical trials and systematic reviews is important for ensuring consistency and homogeneity of findings and comparability of results between the studies. Core outcome sets (COS) are an agreed-upon standardized collection of outcomes that should be measured and reported for a specific area of health. These sets represent the minimum that should be measured and reported in all clinical trials of a specific condition. Utilizing a COS allows for the synthesis of the results of primary studies in a clinically meaningful way [1] . It has been suggested that COS should be routinely used in systematic reviews. The most important advantages of COS are the increase in the amount of usable data for metaanalyses and the improvement in the comparability of studies from the same field [2] .
In 2003, Turk et al. [3] recommended core outcome domains for chronic pain clinical trials within the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), and in 2005, Dworkin et al. [4] recommended specific measures for assessment of those domains. The Pediatric Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (PedIMMPACT) was developed for children age three years and older [5] to encourage standardization of outcome domains in clinical trials of pediatric pain. PedIMMPACT defined two core outcome domains, one for acute pain and another for chronic and recurrent pain in children and adolescents [5] .
To our best knowledge, there are no reports about compliance of systematic reviews on pediatric pain with the COS recommended by PedIMMPACT. Therefore, the aim of this study was to investigate the number and variety of outcomes used in systematic reviews on interventions for postoperative pain and to compare them against the outcomes for acute pain recommended by the PedIMMPACT initiative.
Methods

Study Design
An overview of systematic reviews was conducted. Study was reported according to the PRISMA checklist.
Study Protocol
A protocol for this overview of reviews was developed a priori and registered in the PROSPERO International Prospective Register of Systematic Reviews (No. CRD42015029654).
Searches
Searches were conducted in five electronic databases (MEDLINE, Cochrane Database of Systematic Reviews, DARE, CINAHL, and PsycINFO) from the earliest date to January 31, 2017. Studies in any language were eligible. A complex search strategy was developed for each database.
Types of Studies to Be Included
We analyzed systematic reviews with or without metaanalysis of randomized and quasi-randomized controlled trials evaluating any therapeutic intervention for postoperative pain in children. Participants were defined as patients younger than age 18 years who underwent surgical procedures. Any therapeutic intervention was eligible, pharmacological or nonpharmacological. All comparators were eligible. We excluded the studies that included only children younger than age three years because PedIMMPACT refers to children age three years and older.
Outcomes
All reported efficacy and safety outcomes were analyzed and compared against the outcome domains recommended in the PedIMMPACT [5] . The six outcomes for acute pain defined by the PedIMMPACT COS are pain intensity, global judgment of satisfaction with treatment, symptoms and adverse events, physical recovery, emotional response, and economic factors [5] . Outcomes in Cochrane and non-Cochrane SRs were compared.
Pain Assessment Tools
All SRs, including pain as an outcome, were analyzed to determine if a specific pain assessment tool was indicated in the methods section.
Data Extraction (Selection and Coding)
Titles and abstracts of retrieved records were initially screened independently by two authors (KB, AJK). If at least one author suggested inclusion, the full-text article was retrieved and assessed by two authors (KB, AJK) independently. Disagreements were resolved by the third author (LP). Bibliographic details, primary and secondary outcome measures for efficacy and safety, measurement tools, and follow-up time were extracted by two independent authors (MJ, MB). Discrepancies were resolved by the third author (LP). Outcomes were analyzed and categorized.
Strategy for Data Synthesis
A descriptive data synthesis was performed, and data were presented as frequency and percentage. Pearson's chi-square test was used to calculate differences in proportions. Analyses were conducted with MedCalc statistical software, v. 15.2.1 (MedCalc Software bvba, Ostend, Belgium). Statistical significance was set at P < 0.05.
Results
Literature Search
Search strategy retrieved 1,518 bibliographic records (titles and abstracts). After removing duplicates, we analyzed 1,028 records. We performed duplicate independent screening of those bibliographic records and chose 155 records to analyze in full text. The full text of one manuscript was not available. We found 50 systematic reviews about interventions for pediatric pain, which
Comparison Against the Recommended Core Outcome Set included 866 RCTs. Two SRs included exclusively children under three years [6, 7] . Therefore, these two studies were excluded. The remaining 48 studies included children of various age ranges, and their outcomes were analyzed. A flow diagram of the study selection process is presented in Figure 1 .
Included Studies
The 48 included systematic reviews that matched our inclusion criteria presented data from 816 RCTs. The trials were performed between 2003 and 2017, comprising data on 52,570 participants. Pharmacological interventions were analyzed in 46 systematic reviews, and nonpharmacological in two reviews. List of included studies is presented in the Supplementary Table S1 .
Outcomes Specified in Methods and Reported in Results
The median number of all outcomes was four in both methods (range ¼ 0-7) and results (range ¼ 1 -7) sections. The median number of the PedIMMPACT core outcome domains was three (range ¼ 0-6) in both methods and results sections. A detailed analysis of the presence of six PedIMMPACT core outcomes in the methods section showed that the majority of included reviews indicated in the methods that they planned to analyze symptoms and adverse events (90%) and pain intensity (70%), while the remaining four outcomes were mentioned in less than 50% of methods sections in the included reviews. Among non-PedIMMPACT outcomes identified in the methods, additional analgesia was specified in more than 50% of the SRs, followed by additional opioid analgesia in 21% of SRs. A widely heterogeneous category of outcomes specific to certain interventions was found in half of the SRs; examples are sedation, return of bowel function, time to opening of eyes, procedural time, etc. (Table 1 ). In the results section, the most commonly reported outcome was "symptoms and adverse events" (88%). Pain intensity was the second most frequently reported outcome (75%). The remaining four PedIMMPACT core outcomes were reported in less than 50% of results in the Boric et al.
included reviews. Additional analgesia (65%) was the most frequently reported non-PedIMMPACT outcome ( Table 1) . Six of the 48 included SRs (13%) reported one or more outcomes in the results section that were not specified in the methods.
Cochrane vs Non-Cochrane SRs
Among the 48 included SRs, there were nine Cochrane reviews and 39 non-Cochrane reviews. The nine Cochrane reviews had a total of 50 outcomes prespecified in the methods, and 31 of those were consistent with the PedIMMPACT recommendations (62%). In the 39 non-Cochrane reviews, a total of 148 outcomes were prespecified in the methods, and 88 (59%) were in accordance with PedIMMPACT. The median number of PedIMMPACT outcomes in the methods of Cochrane reviews was three (range ¼ 2-5), and in the nonCochrane reviews it was two (range ¼ 0-4).
There was no significant difference in the proportion of PedIMMPACT outcomes between the two groups (v 2 ¼ 0.025, P ¼ 0.87). In the results section of the Cochrane SRs, 27 out of 43 reported outcomes (63%) were in accordance with PedIMMPACT, while in the non-Cochrane reviews, 91 out of 151 reported outcomes (60%) were in line with PedIMMPACT. The median number of PedIMMPACT outcomes in the results of Cochrane reviews was three (range ¼ 1-5), and in the non-Cochrane reviews it was two (range ¼ 0-4). This difference in proportion of PedIMMPACT outcomes in the results between Cochrane and non-Cochrane SRs was not significant (v 2 ¼ 0.022, P ¼ 0.88).
Pain Assessment Tools Prespecified in the Methods of Systematic Reviews
Among the 34 SRs that specified pain as an outcome in the methods, 19 (56%) also specified pain assessment tools in the methods section. Of eight Cochrane SRs, seven (88%) specified pain assessment tools in the methods, while 12 of 26 non-Cochrane SRs (46%) indicated pain assessment tools that would be extracted. This difference in proportions was significantly different (v 2 ¼ 42.4, P < 0.001). The most commonly specified pain assessment tool (Table 2) in the methods section was the visual analog scale (58%). The numeric rating scale was the second most frequently specified pain assessment tool in the methods (42%).
Discussion
Our results indicate that the authors of SRs on interventions for pediatric pain do not adhere to the COS recommended by the PedIMMPACT initiative. While the median number of all reported outcomes was four, the median number of the PedIMMPACT core outcomes was three out of six. The most commonly reported outcome of the PedIMMPACT COS was "symptoms and adverse events," followed by pain intensity, which was reported in 75% of included SRs. Just above half of the SRs that had pain intensity outcomes also specified pain assessment tools that would be extracted in the methods section. Additional analgesia was reported in more than half of the SRs among non-PedIMMPACT outcomes. Researchers may find this outcome very relevant because it is a secondary measure of the effectiveness of the primary analgesic method. Additional analgesics increase both the cost to the health care system and the risk of adverse drug events.
To our knowledge, this is the first attempt to determine the type and number of outcomes used in systematic reviews of interventions for postoperative pain in children and to compare them with a recommended COS. Clinical trials are conducted to determine the efficacy and safety of interventions in medicine. To conduct such assessments, researchers need to choose outcomes that will measure the benefits and harms of an intervention. The outcomes may be specific to a certain condition or intervention, or they may include broad aspects of health such as pain. Choosing appropriate outcomes and measurement tools is critical in designing clinical trials and systematic reviews of clinical trials in order to allow comparisons of effects across different studies and different interventions [8] .
By using a standardized COS for a specific clinical area, researchers reduce heterogeneity in reported outcomes across trials and enable meaningful evidence synthesis and meta-analyses in systematic reviews. The outcomes do not have to be restricted to the COS; instead, the COS should be used, together with additional relevant outcomes that can be explored [8] . Our findings indicate that recommended COS for pediatric pain did not catch the attention of researchers conducting systematic reviews in this field.
Subgroup analysis for different time periods was not conducted in this study because the PedIMMPACT recommendations were published in 2003 and only one of the included SRs was published in the same year, with no SRs published before that year. The SRs published in the following year might have used COS recommended by the PedIMMPACT. We used PedIMMPACT as a reference for this study because we could not find other published recommendations about the suggested COS for acute pain in children and adolescents. Not all of the outcome domains suggested by the PedIMMPACT have validated measurement tools, and this was clearly emphasized by the PedIMMPACT authors [5] . The lack of specific and validated measures leaves clinical trialists in the field of pediatric pain in a dilemma as to whether to use measures of unknown reliability and validity or to ignore outcome domains that could be relevant for patients and practice. This situation can be remedied only with development and testing of appropriate measurement tools. It has been recommended that trialists in this area of research should test the reliability and validity of various instruments together with primary data collection [5] .
Only three-quarters of the SRs analyzed pain as an outcome. This result is alarming because it means that the SR authors do not find analyzing pain to be an important outcome in evidence synthesis of interventions for pediatric postoperative pain. Almost half of those SRs did not specify in the methods which pain assessment tools would be extracted from the included trials. An analysis of pain assessment tools according to the age of children included in the SRs was not possible because the SRs included very wide ranges of children's ages and did not specify which pain assessment tools were used for different age groups of children.
VAS was the most commonly prespecified pain measurement tool in the methods, and this tool has been recommended for children for age eight years and older [5] . The numeric rating scale was the second most frequently specified pain assessment tool in the methods even though this tool has not been recommended for children age three years and older because of the lack of psychometric studies with the NRS in children and adolescents [5] . All pain assessment tools are not appropriate for all ages. We can only speculate that this scale was used this frequently because the study authors were not familiar with information about the validity of various pain assessment tools in children.
It is possible that the authors of SRs did not use COS defined by PedIMMPACT because they were not familiar with it, or perhaps they did not find the PedIMMPACT COS to be relevant and appropriate.
A comparison of Cochrane vs non-Cochrane SRs revealed that Cochrane SRs had slightly higher compliance with the PedIMMPACT COS. It has been already reported that Cochrane SRs use more rigorous methodology than non-Cochrane SRs [9] and that they are of higher quality and are less biased on average than other systematic reviews [10] . However, even the Cochrane SRs did not comply with the PedIMMPACT COS completely. We did not find a single SR that used all of the six recommended PedIMMPACT outcomes.
Future studies in this field should explore outcomes used in clinical trials about pediatric pain. Authors of systematic reviews and clinical trials in the field of pediatric pain should be queried to understand why they do not use the PedIMMPACT COS and whether they find the COS appropriate. Parents and children should also be involved in studies assessing the relevance and acceptability of recommended outcomes. If necessary, the COS defined by the PedIMMPACT should be revised.
In conclusion, we found that systematic reviews in the field of pediatric pain did not use recommended COS and that they did not even consistently include pain as an outcome. This makes comparisons of efficacy and safety across interventions very difficult. Future studies should explore whether the authors are aware of the COS and whether the recommended COS is appropriate.
